irritable bowel syndrome
Conditions
Interventions
Control Group:Bifico
Experimental Group:Bifico+modified Houpo Zhishi Decoction
Sponsors
Shanghai Seventh People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Meeting the diagnostic criteria for IBS-D classification as interpreted in the "Expert Consensus Opinion on Irritable Bowel Syndrome in China (2020)" and the diagnostic criteria for IBS-D with spleen deficiency syndrome in the "Expert Consensus Opinion on the Diagnosis and Treatment of Irritable Bowel Syndrome in Traditional Chinese Medicine (2017)". 2) Presenting clinical symptoms of IBS-D such as abdominal pain and discomfort during defecation. 3) Having complete clinical data. 4) Having no history of drug allergy.
Exclusion criteria
Exclusion criteria: 1) Mental disorders; 2) Severe organ diseases such as heart, liver and kidney; 3) Pregnant women; 4) Lactating women; 5) Coagulation disorders; 6) Immune system diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IBS-SSS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Prealbumin(PA);Albumin(ALB);motilin(MTL);TCM symptom score;Gastrin(GAS); | — |
Countries
China
Contacts
Public ContactYin benfan
Shanghai Seventh People's Hospital
Outcome results
None listed